Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. | Hepatology | 2014 | 1.05 |
2 | Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. | J Virol Methods | 2010 | 0.78 |
3 | An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant. | Transplantation | 2009 | 0.78 |
4 | Telaprevir-induced DRESS. | J Drugs Dermatol | 2014 | 0.77 |
5 | Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors. | Pancreas | 2011 | 0.75 |